BioLineRx Ltd.
BioLineRx Ltd. (BLRX) — Form SCHEDULE 13G: Ownership over 5% (passive)
About this filing
BioLineRx Ltd. (BLRX) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Nov 16, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More BLRX filings
- 6-K
Filed Nov 18, 2026
- 6-K
Filed Nov 16, 2026
- 6-K
Filed Oct 23, 2026
- EFFECT
Filed Oct 4, 2026
- 424B3
Filed Oct 2, 2026
- F-1
Filed Sep 25, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.